Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC

Summary

Multicentric French parallel double-blind randomized versus placebo study

Timeline

Start

2016-02-23

Primary completion

2018-09-30

Completion

2018-09-30

Publications

• Seneschal J, Duplaine A, Maillard H, Passeron T, Andreu N, Lassalle R, Favary C, Droitcourt C, Taieb A, Ezzedine K. Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study. J Invest Dermatol. 2021 Jul;141(7):1728-1734. doi: 10.1016/j.jid.2020.12.028. Epub 2021 Feb 4.

Drugs

Indications